Product NDC: | 0078-0234 |
Proprietary Name: | Lescol |
Non Proprietary Name: | fluvastatin sodium |
Active Ingredient(s): | 40 mg/1 & nbsp; fluvastatin sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0078-0234 |
Labeler Name: | Novartis Pharmaceuticals Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020261 |
Marketing Category: | NDA |
Start Marketing Date: | 19931230 |
Package NDC: | 0078-0234-05 |
Package Description: | 100 CAPSULE in 1 BOTTLE (0078-0234-05) |
NDC Code | 0078-0234-05 |
Proprietary Name | Lescol |
Package Description | 100 CAPSULE in 1 BOTTLE (0078-0234-05) |
Product NDC | 0078-0234 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fluvastatin sodium |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19931230 |
Marketing Category Name | NDA |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | FLUVASTATIN SODIUM |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |